• Mashup Score: 1

    Ashish Kamat is joined by Wassim Kassouf, an expert in the bladder cancer field on Bacillus Calmette-Guérin unresponsive disease. Together they discuss the different treatment options in these patients, how the shortage of BCG will affect patient samples in clinical studies, and how to counsel patients with BCG-unresponsive carcinoma in situ. Biographies: Wassim Kassouf, MD, CM, FRCSC, is a…

    Tweet Tweets with this article
    • Treatment options for Bacillus Calmette-Guérin #BCG refractory #BladderCancer disease. Wassim Kassouf, MD @mcgillu joins @UroDocAsh @MDAndersonNews in a discussion on UroToday > https://t.co/3A0gi0gUrp #GU20 @ASCO https://t.co/xqjITVGejm

  • Mashup Score: 0

    Phil Koo, MD is joined by Wolfgang Weber, MD sharing his thoughts on the current state of PSMA based therapies. Dr. Weber discusses which patients respond well to this treatment, as well as the research being done to better understand why some patients do not respond well to this treatment. Dr. Weber concludes with a glimpse of things to come for PSMA based therapies. Biographies: Wolfgang…

    Tweet Tweets with this article
    • Targeted radionuclide therapy of #ProstateCancer. Wolfgang Weber, MD @TU_Muenchen joins @PhillipKooMD sharing his thoughts on the state of #PSMA based therapies. #WartchNow on UroToday > https://t.co/3Tq9RcLc5k @ASCO #GU20 https://t.co/YRUztSyTGh

  • Mashup Score: 0

    Phil Koo, MD, and Wolfgang Weber, MD, to share his thoughts on the current state of PSMA based therapies. Dr. Weber discusses which patients respond well to this treatment, as well as the research being done to better understand why some patients do not respond well to this treatment. Dr. Weber concludes with a glimpse of things to come for PSMA based therapies. Biographies: Wolfgang Weber, MD…

    Tweet Tweets with this article
    • Targeted radionuclide therapy of #ProstateCancer. Wolfgang Weber, MD @TU_Muenchen joins @PhillipKooMD sharing his thoughts on the state of #PSMA based therapies. #WartchNow on UroToday > https://t.co/3Tq9RcLc5k @ASCO #GU20 https://t.co/idQsEZmKog

  • Mashup Score: 0

    Ashish Kamat is joined by Wassim Kassouf, an expert in the bladder cancer field on Bacillus Calmette-Guérin unresponsive disease. Together they discuss the different treatment options in these patients, how the shortage of BCG will affect patient samples in clinical studies, and how to counsel patients with BCG-unresponsive carcinoma in situ. Biographies: Wassim Kassouf, MD, CM, FRCSC, is a…

    Tweet Tweets with this article
    • Treatment options for Bacillus Calmette-Guérin #BCG refractory #BladderCancer disease. Wassim Kassouf, MD @mcgillu joins @UroDocAsh @MDAndersonNews in a discussion on UroToday > https://t.co/3A0gi0gUrp #GU20 @ASCO https://t.co/nFqnxdUjS6

  • Mashup Score: 0

    Phil Koo, MD, and Wolfgang Weber, MD, to share his thoughts on the current state of PSMA based therapies. Dr. Weber discusses which patients respond well to this treatment, as well as the research being done to better understand why some patients do not respond well to this treatment. Dr. Weber concludes with a glimpse of things to come for PSMA based therapies. Biographies: Wolfgang Weber, MD…

    Tweet Tweets with this article
    • Targeted radionuclide therapy of #ProstateCancer. Wolfgang Weber, MD @TU_Muenchen joins @PhillipKooMD sharing his thoughts on the state of #PSMA based therapies. #WartchNow on UroToday > https://t.co/3Tq9RcLc5k @ASCO #GU20 https://t.co/mjZrxXF9GT

  • Mashup Score: 0

    Ashish Kamat is joined by Wassim Kassouf, an expert in the bladder cancer field on Bacillus Calmette-Guérin unresponsive disease. Together they discuss the different treatment options in these patients, how the shortage of BCG will affect patient samples in clinical studies, and how to counsel patients with BCG-unresponsive carcinoma in situ. Biographies: Wassim Kassouf, MD, CM, FRCSC, is a…

    Tweet Tweets with this article
    • Treatment options for Bacillus Calmette-Guérin #BCG refractory #BladderCancer disease. Wassim Kassouf, MD @mcgillu joins @UroDocAsh @MDAndersonNews in a discussion on UroToday > https://t.co/3A0gi0gUrp #GU20 @ASCO https://t.co/XodDKm8TQn